NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-185-1995-0-GB-08 INHIBITORY AND NON-INHIBITORY ANTIGEN BINDING POLYPEPTIDES AGAINST HUMAN P450 ENZYMES GB EP 96939561.5 Expired
NCI E-185-1995-0-AU-03 INHIBITORY AND NON-INHIBITORY ANTIGEN BINDING POLYPEPTIDES AGAINST HUMAN P450 ENZYMES AU National Stage 76701/96 Expired
NCI E-185-1995-0-PCT-02 INHIBITORY AND NON-INHIBITORY ANTIGEN BINDING POLYPEPTIDES AGAINST HUMAN P450 ENZYMES PCT PCT PCT/US96/17781 Expired
NCI E-008-1997-0-US-01 VANILLOID AGONISTS AND DESENSITIZATION OF C-FIBER SENSORY AFFERENT NEURONS US 60/030,999 Abandoned
NIMH E-159-1997-0-US-01 REGULATION OF NEUROENDOCRINE AND REPRODUCTIVE FUNCTION US ORD 08/749,534 Abandoned
NCI E-029-1996-0-PCT-02 No_Patent_Title PCT PCT PCT/US96/18829 Abandoned
NIDA E-131-1993-1-US-02 NOVEL AND SELECTIVE INHIBITORS OF BIOGENIC AMINE TRANSPORTERS US DIV 08/746,517 5747503 Expired PDF
NHLBI E-007-1996-0-GB-10 USE OF LECITHIN-CHOLESTEROL ACYLTRANSFERASE (LCAT) IN THE TREATMENT OF ATHEROSCLEROSIS GB EP 96940403.7 Expired
NHLBI E-007-1996-0-FR-09 USE OF LECITHIN-CHOLESTEROL ACYLTRANSFERASE (LCAT) IN THE TREATMENT OF ATHEROSCLEROSIS FR EP 96940403.7 Expired
NHLBI E-007-1996-0-DE-07 USE OF LECITHIN-CHOLESTEROL ACYLTRANSFERASE (LCAT) IN THE TREATMENT OF ATHEROSCLEROSIS DE EP 96940403.7 Expired
NHLBI E-007-1996-0-IT-11 USE OF LECITHIN-CHOLESTEROL ACYLTRANSFERASE (LCAT) IN THE TREATMENT OF ATHEROSCLEROSIS IT EP 96940403.7 Expired
NHLBI E-007-1996-0-ES-08 USE OF LECITHIN-CHOLESTEROL ACYLTRANSFERASE (LCAT) IN THE TREATMENT OF ATHEROSCLEROSIS ES EP 96940403.7 Expired
NHLBI E-007-1996-0-CA-06 USE OF LECITHIN-CHOLESTEROL ACYLTRANSFERASE (LCAT) TO REDUCE ACCUMULATION OF CHOLESTEROL CA National Stage 2236982 Expired
NHLBI E-007-1996-0-EP-04 USE OF LECITHIN-CHOLESTEROL ACYLTRANSFERASE (LCAT)TO REDUCE ACCUMULATION OF CHOLESTEROL EP National Stage 96940403.7 Expired
NHLBI E-007-1996-0-AU-05 USE OF LECITHIN-CHOLESTEROL ACYLTRANSFERASE (LCAT) IN THE TREATMENT OF ATHEROSCLEROSIS AU National Stage 77293/96 Expired
NIAAA E-014-1996-1-US-01 ALLELIC VARIATION OF THE SEROTONIN 5HT7 RECEPTOR US ORD 08/745,269 5763183 Expired PDF
NHLBI E-007-1996-0-PCT-02 USE OF LECITHIN-CHOLESTEROL ACYLTRANSFERASE (LCAT) IN THE TREATMENT OF ATHEROSCLEROSIS PCT PCT PCT/US1996/018159 Expired
NIDDK E-009-1997-0-US-01 SYNTHESIS AND PURIFICATION OF HEPATITIS C VIRUS-LIKE PARTICLES IN VITRO US 60/030,238 Abandoned
NCI E-022-1997-0-US-01 MODIFIED PSEUDOMONAS EXOTOXIN PROPROTEINS US 60/030,376 Abandoned
NIAID E-147-1997-0-US-01 CERTAIN AMINOSTEROL COMPOUNDS AND USES THEREOF US 60/029,541 Abandoned
NCI E-210-1995-2-US-01 Epithelial Protein And DNA Thereof For Use in Early Cancer Detection US CIP 08/725,027 6251586 Abandoned PDF
NIDA E-152-1996-0-US-01 SUBTAINED RELEASE DERIVATIVES OF HYDROXYLATED ANALOGS OF SUBSTITUTED 1-[2[BIS(ARYL)METHOXY]ETHYL]-PIPERAZINES AND -HOMOPIPERAZINES AND ... US 60/030,248 Abandoned
NCI E-187-1992-0-US-08 AMINO ACID SEQUENCING PEPTIDES AND METHODS FOR THEIR USE US DIV 08/739,819 5919709 Abandoned PDF
NCI E-175-1996-0-US-01 GENETIC RESTRICTION OF HIV-1 INFECTION AND PROGRESSION TO AIDS BY A DELETION ALLELE OF THE CKR5 STRUCTURAL GENE US 60/029,388 Abandoned
NIDDK E-085-1999-0-US-01 P2Y Receptor Antagonists US 60/029,855 Abandoned
NIMH E-189-1995-0-US-02 IMMUNOTOXIN WITH IN VIVO T CELL SUPPRESSANT ACTIVITY AND METHODS OF USE US ORD 08/739,703 Abandoned
NIMH E-014-1997-0-US-01 CHROMOSOMAL MARKERS AND DIAGNOSTIC TESTS FOR MANIC-DEPRESSIVE ILLNESS US 60/029,278 Abandoned
NCI E-009-1996-0-US-01 METHODS AND COMPOSITIONS FOR INHIBITING INFLAMMATION AND ANGIOGENESIS US 60/027,871 Abandoned
NCI E-093-1995-1-EP-03 CHIMERIC RECEPTOR GENES AND CELLS TRANSFORMED THEREWITH EP National Stage 93908414.1 Expired
NCI E-093-1995-1-PCT-02 CHIMERIC RECEPTOR GENES AND CELLS TRANSFORMED THEREWITH PCT PCT PCT/US1996/017060 Abandoned
NCI E-022-2006-2-US-08 Peptides Recognized By Melanoma-specific Cytoxic Lyphocytes, And Uses Therefor US National Stage 08/682,768 Abandoned
NIMH E-241-1995-1-US-02 GLYCOLIPID ENZYME POLYMER CONJUGATES US DIV 08/735,961 5705153 Expired PDF
NCI E-057-1994-3-JP-06 MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS JP National Stage 527821/95 Expired
NCI E-113-1994-1-US-01 ISOLATION AND CHARACTERIZATION OF A NOVEL PRIMATE T-CELL LYMPHOTROPIC VIRUS AND THE USE OF THIS VIRUS OR COMPONENTS THEREOF IN... US CIP 08/727,471 Abandoned
NHGRI E-217-1995-1-CA-04 SEQUENCE MODIFICATION OF OLIGONUCLEOTIDE PRIMERS TO MAINIPULATE NON-TEMPLATED NUCLEOTIDE ADDITION CA National Stage 2235327 Abandoned
NHGRI E-217-1995-1-IT-13 SEQUENCE MODIFICATION OF OLIGONUCLEOTIDE PRIMERS TO MAINIPULATE NON-TEMPLATED NUCLEOTIDE ADDITION IT EP 96936547.7 Abandoned
NHGRI E-217-1995-1-IE-12 SEQUENCE MODIFICATION OF OLIGONUCLEOTIDE PRIMERS TO MAINIPULATE NON-TEMPLATED NUCLEOTIDE ADDITION IE EP 96936547.7 Abandoned
NHGRI E-217-1995-1-SE-15 SEQUENCE MODIFICATION OF OLIGONUCLEOTIDE PRIMERS TO MAINIPULATE NON-TEMPLATED NUCLEOTIDE ADDITION SE EP 96936547.7 Abandoned
NHGRI E-217-1995-1-CH-16 SEQUENCE MODIFICATION OF OLIGONUCLEOTIDE PRIMERS TO MAINIPULATE NON-TEMPLATED NUCLEOTIDE ADDITION CH EP 96936547.7 Abandoned
NHGRI E-217-1995-1-GB-17 SEQUENCE MODIFICATION OF OLIGONUCLEOTIDE PRIMERS TO MAINIPULATE NON-TEMPLATED NUCLEOTIDE ADDITION GB EP 96936547.7 Abandoned
NHGRI E-217-1995-1-BE-07 SEQUENCE MODIFICATION OF OLIGONUCLEOTIDE PRIMERS TO MAINIPULATE NON-TEMPLATED NUCLEOTIDE ADDITION BE EP 96936547.7 Abandoned
NHGRI E-217-1995-1-AT-06 SEQUENCE MODIFICATION OF OLIGONUCLEOTIDE PRIMERS TO MAINIPULATE NON-TEMPLATED NUCLEOTIDE ADDITION AT EP 96936547.7 Abandoned
NHGRI E-217-1995-1-EP-05 SEQUENCE MODIFICATION OF OLIGONUCLEOTIDE PRIMERS TO MAINIPULATE NON-TEMPLATED NUCLEOTIDE ADDITION EP National Stage 96936547.7 Abandoned
NHGRI E-217-1995-1-DK-08 SEQUENCE MODIFICATION OF OLIGONUCLEOTIDE PRIMERS TO MAINIPULATE NON-TEMPLATED NUCLEOTIDE ADDITION DK EP 96936547.7 Abandoned
NHGRI E-217-1995-1-FI-09 SEQUENCE MODIFICATION OF OLIGONUCLEOTIDE PRIMERS TO MAINIPULATE NON-TEMPLATED NUCLEOTIDE ADDITION FI EP 96936547.7 Abandoned
NHGRI E-217-1995-1-LU-18 SEQUENCE MODIFICATION OF OLIGONUCLEOTIDE PRIMERS TO MAINIPULATE NON-TEMPLATED NUCLEOTIDE ADDITION LU EP 96936547.7 Abandoned
NHGRI E-217-1995-1-NL-14 SEQUENCE MODIFICATION OF OLIGONUCLEOTIDE PRIMERS TO MAINIPULATE NON-TEMPLATED NUCLEOTIDE ADDITION NL EP 96936547.7 Abandoned
NHGRI E-217-1995-1-MC-19 SEQUENCE MODIFICATION OF OLIGONUCLEOTIDE PRIMERS TO MAINIPULATE NON-TEMPLATED NUCLEOTIDE ADDITION MC EP 96936547.7 Abandoned
NHGRI E-217-1995-1-FR-10 SEQUENCE MODIFICATION OF OLIGONUCLEOTIDE PRIMERS TO MAINIPULATE NON-TEMPLATED NUCLEOTIDE ADDITION FR EP 96936547.7 Abandoned
NHGRI E-217-1995-1-DE-11 SEQUENCE MODIFICATION OF OLIGONUCLEOTIDE PRIMERS TO MAINIPULATE NON-TEMPLATED NUCLEOTIDE ADDITION DE EP 96936547.7 Abandoned